The Biotech Growth Trust Plc Compliance with Market Abuse Regulation
11 Outubro 2023 - 5:54AM
UK Regulatory
TIDMBIOG
The Biotech Growth Trust PLC (the "Company")
Compliance with Market Abuse Regulation
11 October 2023
The Company confirms that:
a) all inside information which the Directors and Company may have had
has been notified to a Regulated Information Service ("RIS");
b) the Company's net asset value per share is calculated and announced
through a RIS on a daily basis; and
c) the Company does not believe that there will be a material difference
between the net asset value per share as at close of business on Friday, 29
September 2023, which was announced on Monday, 2 October 2023, and the financial
information to be published in the announcement of its results for the half year
ended 30 September 2023.
The Company is, therefore, not prohibited from dealing in its own securities
during the closed period, as defined by the Market Abuse Regulation, which will
end on the date of the publication of its results for the half year ended 30
September 2023, expected to be on or after 9 November 2023.
-ENDS-
For further information please contact:
Katherine Manson Frostrow Capital LLP 020 3709 8734
This information was brought to you by Cision http://news.cision.com
END
(END) Dow Jones Newswires
October 11, 2023 04:54 ET (08:54 GMT)
Biotech Growth (LSE:BIOG)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Biotech Growth (LSE:BIOG)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024